297 related articles for article (PubMed ID: 36641897)
21. Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
[TBL] [Abstract][Full Text] [Related]
22. B-Sure: a randomized pilot trial of an interactive web-based decision support aid versus usual care in average-risk breast cancer patients considering contralateral prophylactic mastectomy.
Manne SL; Smith BL; Frederick S; Mitarotondo A; Kashy DA; Kirstein LJ
Transl Behav Med; 2020 May; 10(2):355-363. PubMed ID: 30608607
[TBL] [Abstract][Full Text] [Related]
23. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
Panchal H; Pilewskie ML; Sheckter CC; Albornoz CR; Razdan SN; Disa JJ; Cordeiro PG; Mehrara BJ; Matros E
J Surg Oncol; 2019 Jan; 119(1):79-87. PubMed ID: 30480805
[TBL] [Abstract][Full Text] [Related]
24. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
[TBL] [Abstract][Full Text] [Related]
25. Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
Mamtani A; Sjoberg DD; Vincent A; Ehdaie B; Malhotra D; Vickers A; Morrow M
Breast Cancer Res Treat; 2023 May; 199(1):119-126. PubMed ID: 36881270
[TBL] [Abstract][Full Text] [Related]
26. Issues of regret in women with contralateral prophylactic mastectomies.
Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
[TBL] [Abstract][Full Text] [Related]
27. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Demsky R; Mancuso T; Sun P; Narod SA
Ann Surg Oncol; 2021 Sep; 28(9):4967-4973. PubMed ID: 33761021
[TBL] [Abstract][Full Text] [Related]
28. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
29. Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.
Richards I; Tesson S; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
Eur J Oncol Nurs; 2016 Apr; 21():57-65. PubMed ID: 26952679
[TBL] [Abstract][Full Text] [Related]
30. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
Huang J; Chagpar A
J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
[TBL] [Abstract][Full Text] [Related]
31. Operating on Anxiety: Negative Affect toward Breast Cancer and Choosing Contralateral Prophylactic Mastectomy.
Silverstein MC; Lee CN; Scherer LD; Phommasathit C; Merrill AL; Peters E
Med Decis Making; 2023 Feb; 43(2):152-163. PubMed ID: 36059240
[TBL] [Abstract][Full Text] [Related]
32. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
Tollow P; Williams VS; Harcourt D; Paraskeva N
Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
[TBL] [Abstract][Full Text] [Related]
33. Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
Allué Cabañuz M; Domingo Bretón M; Chóliz Ezquerro J; Arribas Del Amo MD; Güemes Sánchez AT
Cir Esp (Engl Ed); 2020 Dec; 98(10):612-617. PubMed ID: 32505558
[TBL] [Abstract][Full Text] [Related]
34. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
[TBL] [Abstract][Full Text] [Related]
35. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
Graves KD; Peshkin BN; Halbert CH; DeMarco TA; Isaacs C; Schwartz MD
Breast Cancer Res Treat; 2007 Sep; 104(3):321-9. PubMed ID: 17066320
[TBL] [Abstract][Full Text] [Related]
36. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer.
Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR
Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939
[TBL] [Abstract][Full Text] [Related]
37. Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy.
Davies KR; Cantor SB; Brewster AM
Int J Womens Health; 2015; 7():181-7. PubMed ID: 25678823
[TBL] [Abstract][Full Text] [Related]
38. The use of contralateral prophylactic mastectomy among elderly patients in the United States.
Marmor S; Altman AM; Mayleben WT; Hui JYC; Denbo JW; Jensen EH; Tuttle TM
Breast Cancer Res Treat; 2019 Aug; 177(1):175-183. PubMed ID: 31140081
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer.
Keskey RC; LaJoie AS; Sutton BS; Kim IK; Cheadle WG; McMasters KM; Ajkay N
Ann Surg Oncol; 2017 Dec; 24(13):3903-3910. PubMed ID: 29039025
[TBL] [Abstract][Full Text] [Related]
40. The implementation of a decision aid for women with early-stage breast cancer considering contralateral prophylactic mastectomy: A pilot study.
Jansen J; Serafimovska A; Glassey R; Zdenkowski N; Saunders C; Porter D; Butow P
Patient Educ Couns; 2022 Jan; 105(1):74-80. PubMed ID: 34034935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
